1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Age-Related Memory Disorders in 12 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, TT | 1 |
| Kim, KS | 1 |
| Shin, KS | 1 |
| Park, HJ | 1 |
| Kim, HJ | 1 |
| Lee, KE | 1 |
| Lee, MK | 1 |
| Zhu, G | 1 |
| Li, J | 1 |
| He, L | 2 |
| Wang, X | 1 |
| Hong, X | 1 |
| Rajput, SK | 1 |
| Sharma, AK | 1 |
| Meena, CL | 1 |
| Pant, AB | 1 |
| Jain, R | 1 |
| Sharma, SS | 1 |
| Kakefuda, K | 1 |
| Fujita, Y | 1 |
| Oyagi, A | 1 |
| Hyakkoku, K | 1 |
| Kojima, T | 1 |
| Umemura, K | 1 |
| Tsuruma, K | 1 |
| Shimazawa, M | 1 |
| Ito, M | 1 |
| Nozawa, Y | 1 |
| Hara, H | 1 |
| Monaghan, MM | 1 |
| Leddy, L | 1 |
| Sung, ML | 1 |
| Albinson, K | 1 |
| Kubek, K | 1 |
| Pangalos, MN | 1 |
| Reinhart, PH | 1 |
| Zaleska, MM | 1 |
| Comery, TA | 1 |
| Hsieh, MH | 1 |
| Gu, SL | 1 |
| Ho, SC | 1 |
| Pawlak, CR | 1 |
| Lin, CL | 1 |
| Ho, YJ | 1 |
| Lai, TJ | 1 |
| Wu, FY | 1 |
| Castro, AA | 1 |
| Ghisoni, K | 1 |
| Latini, A | 1 |
| Quevedo, J | 1 |
| Tasca, CI | 1 |
| Prediger, RD | 1 |
| Da Cunha, C | 4 |
| Wietzikoski, S | 1 |
| Wietzikoski, EC | 1 |
| Miyoshi, E | 2 |
| Ferro, MM | 1 |
| Anselmo-Franci, JA | 1 |
| Canteras, NS | 3 |
| Yang, J | 1 |
| Wang, J | 1 |
| Adams, JD | 1 |
| Braga, R | 1 |
| Kouzmine, I | 1 |
| Gevaerd, MS | 2 |
| Takahashi, RN | 2 |
| Silveira, R | 2 |
12 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Chemistry; Disease Mo | 2017 |
MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Ag | 2015 |
Effect of L-pGlu-(1-benzyl)-l-His-l-Pro-NH
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Ischemia; Catalepsy; Cell Death; Diseas | 2016 |
Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Ischemia; Memory Disorders; Mice; Mice, | 2009 |
Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Disease Models, Animal; | 2010 |
Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Brain; Disease Models, | 2012 |
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Age Factors; Animals; Anim | 2012 |
Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine Agents; Male; Maze | 2003 |
Early administration of nicotinamide prevents learning and memory impairment in mice induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Learning; Male; Memory Disorders; Mice; Niaci | 2004 |
Lesion of the substantia nigra, pars compacta impairs delayed alternation in a Y-maze in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cognition Disorders; Denervation; Disease Mod | 2005 |
Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Avoidance Learning; Caffeine; Central Nervous | 2001 |
L-Dopa restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Avoidance Learning; Ben | 2001 |